ReviewFrontiers in clinical diabetes and healthcare2025
Benefits of SGLT2 inhibitors in patients with diabetes and advanced chronic kidney disease - where have we gone so far?
Anila Duni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.